Leuko
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
15
11 to 50 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
1
tools in use
Monthly traffic
428
organic / mo
Sign up free to see all 9 verified contacts at Leuko
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- IB
Ian Butterworth
Cofounder & CTO · Other
EmailPhone - AP
Alberto Pablo Trinidad
Deep Learning Engineering · Information Technology
EmailPhone - RB
Ryan Benasutti
Senior Software Engineer · Information Technology
EmailPhone - AS
Alvaro Sanchez-Ferro
Cofounder Chief Medical Officer · Other
EmailPhone
Showing 4 of 9 verified contacts
Top roles at Leuko
8 distinct titles indexed · top 8 shown.
- 1business analyst intern
- 1cofounder & cto
- 1cofounder chief medical officer
- 1deep learning engineering
- 1machine learning engineer
- 1senior human factors engineer
- 1senior software engineer
- 1vice president
Sign up to unlock all 9 contacts at Leuko
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Leuko
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.